JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on ProQR (PRQR β Research Report) today and set a price target of $31.00. The...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM&n...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
TABLE OF CONTENTS Filed pursuant to Rule 424(b)(5) Registration no...
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on November 4...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM ...
By Chris Wack ProQR Therapeutics N.V. shares were up 29% to $8.76 after the company said it entered into a global licensing and research...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads